Guillaume Hache

Uremic Toxic Blood-Brain Barrier Disruption Mediated by AhR Activation Leads to Cognitive Impairment during Experimental Renal Dysfunction

Mickaël Bobot, Laurent F. Thomas, Anaïs Moyon et al. · Journal of the American Society of Nephrology · 2020 · 158 citations · Full text

P2X7 Cell Death Receptor Activation and Mitochondrial Impairment in Oxaliplatin-Induced Apoptosis and Neuronal Injury: Cellular Mechanisms and In Vivo Approach

France Massicot, Guillaume Hache, Ludivine David et al. · PLoS ONE · 2013 · 58 citations · Full text

Pain Medicine, Lipid Peroxidation, Apoptosis +24

Monoaminergic Antidepressants in the Relief of Pain: Potential Therapeutic Utility of Triple Reuptake Inhibitors (TRIs)

Guillaume Hache, François Coudoré, Alain M. Gardier et al. · Pharmaceuticals · 2011 · 37 citations · Full text

Pain Therapy, Pain Medicine, Psychotropic Medication +28

Antinociceptive effects of fluoxetine in a mouse model of anxiety/depression

Guillaume Hache, Bruno P. Guiard, Yannick Le Dantec et al. · Neuroreport · 2012 · 35 citations

Pain Disorders, Pain Medicine, Psychotropic Medication +24

Antinociceptive activity of the new triple reuptake inhibitor<scp>NS</scp>18283 in a mouse model of chemotherapy‐induced neuropathic pain

Guillaume Hache, Bruno P. Guiard, T.H. Nguyen et al. · European Journal of Pain · 2014 · 34 citations